IRE1&agr; RNase–dependent lipid homeostasis promotes survival in Myc-transformed cancers
暂无分享,去创建一个
C. Dang | A. Mancuso | Jin Cao | J. D. Del Valle | C. Hu | M. Simon | B. Keith | C. Tang | Danielle J. Sanchez | H. Xie | Jun H Song | Yan Xiang | Roy Lan | Juan R. Del Valle
[1] A. P. Kolesnichenko,et al. Acute lung injury , 2020, Intensive Care Medicine.
[2] G. Rabinovich,et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity , 2018, Nature.
[3] Kuan-Der Lee,et al. ER stress‐related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer , 2018, Molecular oncology.
[4] Sean M. Hartig,et al. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer , 2018, The Journal of clinical investigation.
[5] D. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[6] Wei Wei,et al. Melatonin, a novel selective ATF-6 inhibitor, induces human hepatoma cell apoptosis through COX-2 downregulation , 2017, World journal of gastroenterology.
[7] L. Chin,et al. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer , 2017, Nature.
[8] Lizhi Song,et al. A critical role of DDRGK1 in endoplasmic reticulum homoeostasis via regulation of IRE1α stability , 2017, Nature Communications.
[9] J. Joyce,et al. STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation. , 2016, Cell reports.
[10] A. Califano,et al. HAUSP deubiquitinated and stabilizes N-Myc in neuroblastoma , 2016, Nature Medicine.
[11] C. Hetz,et al. Endoplasmic Reticulum Stress and the Hallmarks of Cancer. , 2016, Trends in cancer.
[12] A. Papavassiliou,et al. XBP1: A Pivotal Transcriptional Regulator of Glucose and Lipid Metabolism , 2016, Trends in Endocrinology & Metabolism.
[13] A. Burke,et al. Update on non-Hodgkin lymphoma in children , 2016 .
[14] D. Hallahan,et al. The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma , 2015, Oncotarget.
[15] S. Kersten,et al. IRE1α is an endogenous substrate of endoplasmic reticulum-associated degradation , 2015, Nature Cell Biology.
[16] R. Schreiber,et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.
[17] Jian-hua Li,et al. Spliced XBP1 promotes macrophage survival and autophagy by interacting with Beclin-1. , 2015, Biochemical and biophysical research communications.
[18] D. Tuveson,et al. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1 , 2015, Cell.
[19] M. Feldman,et al. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. , 2015, The Journal of clinical investigation.
[20] L. Glimcher,et al. The transcription factor XBP1 is selectively required for eosinophil differentiation , 2015, Nature Immunology.
[21] Juan R. Cubillos-Ruiz,et al. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis , 2015, Cell.
[22] A. McCallion,et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. , 2015, The Journal of clinical investigation.
[23] Brian Keith,et al. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. , 2015, Cancer discovery.
[24] H. Molly,et al. Tumor growth in vivo. , 2015 .
[25] J. Hurley,et al. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. , 2015, Cancer cell.
[26] M. McKeown,et al. Therapeutic strategies to inhibit MYC. , 2014, Cold Spring Harbor perspectives in medicine.
[27] R. Kaufman,et al. The impact of the endoplasmic reticulum protein-folding environment on cancer development , 2014, Nature Reviews Cancer.
[28] G. Evan,et al. Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis , 2014, Nature Communications.
[29] M. Simon,et al. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. , 2014, Trends in cell biology.
[30] R. Tibshirani,et al. Alteration of the lipid profile in lymphomas induced by MYC overexpression , 2014, Proceedings of the National Academy of Sciences.
[31] C. Cubitt,et al. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. , 2014, The Journal of clinical investigation.
[32] D. Felsher,et al. MYC activation is a hallmark of cancer initiation and maintenance. , 2014, Cold Spring Harbor perspectives in medicine.
[33] Joseph E Chambers,et al. Endoplasmic reticulum stress in malignancy. , 2014, Cancer cell.
[34] M. Ferrari,et al. XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway , 2014, Nature.
[35] L. Staudt,et al. Oncogenic mechanisms in Burkitt lymphoma. , 2014, Cold Spring Harbor perspectives in medicine.
[36] F. Brandizzi,et al. IRE1: ER stress sensor and cell fate executor. , 2013, Trends in cell biology.
[37] William A Weiss,et al. Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.
[38] A. Hassell,et al. Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development. , 2013, ACS medicinal chemistry letters.
[39] G. Juhász,et al. Myc-Driven Overgrowth Requires Unfolded Protein Response-Mediated Induction of Autophagy and Antioxidant Responses in Drosophila melanogaster , 2013, PLoS genetics.
[40] C. Dang. MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.
[41] A. Mancuso,et al. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. , 2013, Genes & development.
[42] E. White,et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.
[43] Christian M. Metallo,et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.
[44] J. Copland,et al. Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma , 2013, Clinical Cancer Research.
[45] O. Sansom,et al. MYC‐y mice: From tumour initiation to therapeutic targeting of endogenous MYC , 2013, Molecular oncology.
[46] D. Ron,et al. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains , 2013, Proceedings of the National Academy of Sciences.
[47] K. Stegmaier,et al. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. , 2013, Cancer discovery.
[48] A. Harris,et al. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth , 2013, Cancer & Metabolism.
[49] C. Koumenis,et al. PERK-ing up autophagy during MYC-induced tumorigenesis , 2013, Autophagy.
[50] I. Mills,et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. , 2012, The Journal of clinical investigation.
[51] Qingbo Xu,et al. XBP1 mRNA Splicing Triggers an Autophagic Response in Endothelial Cells through BECLIN-1 Transcriptional Activation* , 2012, The Journal of Biological Chemistry.
[52] L. Glimcher,et al. Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. , 2012, Cell metabolism.
[53] C. Croce,et al. Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. , 2012, Blood.
[54] C. Harrison,et al. Burkitt's lymphoma , 2012, The Lancet.
[55] Chi V Dang,et al. MYC on the Path to Cancer , 2012, Cell.
[56] B. Wang,et al. SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids , 2012, PloS one.
[57] R. Silverman,et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule , 2012, Proceedings of the National Academy of Sciences.
[58] C. Hetz. The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.
[59] N. Munshi,et al. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma. , 2011, Blood.
[60] E. White,et al. Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism. , 2011, Analytical chemistry.
[61] R. Young,et al. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.
[62] J. Tamburini,et al. Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia , 2010, Clinical Cancer Research.
[63] Liu Yang,et al. A Phos-Tag-Based Approach Reveals the Extent of Physiological Endoplasmic Reticulum Stress , 2010, PloS one.
[64] C. Dang,et al. Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model , 2010, Proceedings of the National Academy of Sciences.
[65] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[66] Geoffrey L. Francis,et al. Albumin and mammalian cell culture: implications for biotechnology applications , 2010, Cytotechnology.
[67] Annette M. McGehee,et al. XBP-1-Deficient Plasmablasts Show Normal Protein Folding but Altered Glycosylation and Lipid Synthesis1 , 2009, The Journal of Immunology.
[68] J. Weissman,et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells , 2009, The Journal of cell biology.
[69] R. Clarke,et al. The role of X-box binding protein-1 in tumorigenicity. , 2009, Drug news & perspectives.
[70] B. Hoffman,et al. Apoptotic signaling by c-MYC , 2008, Oncogene.
[71] Davide Ruggero,et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.
[72] Martin-Leo Hansmann,et al. Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis , 2008, The Journal of experimental medicine.
[73] L. Glimcher,et al. Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.
[74] M. Hogarty,et al. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells , 2008, Oncogene.
[75] Thomas C. Chen,et al. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. , 2007, Cancer research.
[76] G. Morgan,et al. Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. , 2007, Blood.
[77] Nathan H. Lents,et al. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. , 2007, Molecular cell.
[78] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[79] S. Elledge,et al. The ubiquitin-specific protease USP28 is required for MYC stability , 2007, Nature Cell Biology.
[80] Bianca Sperl,et al. Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine , 2007, ChemMedChem.
[81] Adam A. Margolin,et al. Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.
[82] F. Moatamed,et al. In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model. , 2004, Blood.
[83] Gerard Lozanski,et al. Adult Burkitt leukemia and lymphoma. , 2004, Blood.
[84] M. Bjornsti,et al. The tor pathway: a target for cancer therapy , 2004, Nature Reviews Cancer.
[85] L. Glimcher,et al. XBP-1 Regulates a Subset of Endoplasmic Reticulum Resident Chaperone Genes in the Unfolded Protein Response , 2003, Molecular and Cellular Biology.
[86] Kathryn A. O’Donnell,et al. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets , 2003, Genome Biology.
[87] Neal N. Iwakoshi,et al. Plasma cell differentiation requires the transcription factor XBP-1 , 2001, Nature.
[88] Chen-feng Qi,et al. Burkitt Lymphoma in the Mouse , 2000, The Journal of experimental medicine.
[89] F. Alt,et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. , 2000, Genes & development.
[90] F. Urano,et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.
[91] Robert A. Weinberg,et al. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.
[92] J. Bishop,et al. Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29 , 1978, Journal of virology.
[93] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[94] Robert E. Cooke,et al. Perspectives in Medicine , 1949, The Yale Journal of Biology and Medicine.
[95] J. Ochocki,et al. HIF-2α dependent lipid storage promotes endoplasmic reticulum homeostasis in clear cell renal cell carcinoma , 2015 .
[96] Mauro Ferrari,et al. XBP 1 Promotes Triple Negative Breast Cancer By Controlling the HIF 1 α Pathway , 2014 .
[97] Erin Murphy,et al. SCD 1 Inhibition Causes Cancer Cell Death by Depleting MonoUnsaturated Fatty Acids , 2012 .
[98] J. Ntambi,et al. Stearoyl CoA desaturase 1: role in cellular inflammation and stress. , 2011, Advances in nutrition.
[99] F. Urano,et al. Measuring ER stress and the unfolded protein response using mammalian tissue culture system. , 2011, Methods in enzymology.
[100] P. Damas,et al. [Inflammation and stress]. , 1999, Revue medicale de Liege.